Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 140

1.

The Relation of Focal Lesions to Cortical Thickness in Pediatric Traumatic Brain Injury.

Bigler ED, Zielinski BA, Goodrich-Hunsaker N, Black GM, Huff BS, Christiansen Z, Wood DM, Abildskov TJ, Dennis M, Taylor HG, Rubin K, Vannatta K, Gerhardt CA, Stancin T, Yeates KO.

J Child Neurol. 2016 Oct;31(11):1302-11. doi: 10.1177/0883073816654143. Epub 2016 Jun 24.

PMID:
27342577
2.

Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice.

McNeill RS, Schmid RS, Bash RE, Vitucci M, White KK, Werneke AM, Constance BH, Huff B, Miller CR.

J Vis Exp. 2014 Aug 12;(90):e51763. doi: 10.3791/51763.

3.

Medical-surgical nurses' perceived self-confidence and leadership abilities as first responders in acute patient deterioration events.

Hart PL, Spiva L, Baio P, Huff B, Whitfield D, Law T, Wells T, Mendoza IG.

J Clin Nurs. 2014 Oct;23(19-20):2769-78. doi: 10.1111/jocn.12523. Epub 2014 Jan 7.

PMID:
24393472
4.

Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.

Vitucci M, Karpinich NO, Bash RE, Werneke AM, Schmid RS, White KK, McNeill RS, Huff B, Wang S, Van Dyke T, Miller CR.

Neuro Oncol. 2013 Oct;15(10):1317-29. doi: 10.1093/neuonc/not084. Epub 2013 Jun 27.

5.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team..

N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.

6.

Overlooked and underserved: "action signs" for identifying children with unmet mental health needs.

Jensen PS, Goldman E, Offord D, Costello EJ, Friedman R, Huff B, Crowe M, Amsel L, Bennett K, Bird H, Conger R, Fisher P, Hoagwood K, Kessler RC, Roberts R.

Pediatrics. 2011 Nov;128(5):970-9. doi: 10.1542/peds.2009-0367. Epub 2011 Oct 24.

7.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team..

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

8.

Renewed hope. "Efforts to discover a cure for HIV take on a new life--but it still won't be easy.

Huff B.

Posit Aware. 2010 Sep-Oct;22(5):19-22. No abstract available.

PMID:
21033039
9.

Variolins and related alkaloids.

Walker SR, Carter EJ, Huff BC, Morris JC.

Chem Rev. 2009 Jul;109(7):3080-98. doi: 10.1021/cr900032s. Review. No abstract available.

PMID:
19489543
10.

A rare moment in time.

Huff B.

GMHC Treat Issues. 2007 Jan-Mar;21(1):12. No abstract available.

PMID:
17722333
11.

Studying new drugs for HCV. Excerpts from the FDA hearing.

Huff B.

GMHC Treat Issues. 2006 Aug-Dec;20(8-12):11-4. No abstract available.

PMID:
17569164
12.

14th retrovirus conference on the Web.

Huff B.

GMHC Treat Issues. 2006 Aug-Dec;20(8-12):7-9. No abstract available.

PMID:
17569162
13.

Something new under the sun. Maraviroc poised for approval.

Huff B.

GMHC Treat Issues. 2006 Aug-Dec;20(8-12):1-4. No abstract available.

PMID:
17569160
14.

What the world needs now. New HIV drugs for the next decade.

Huff B.

Posit Aware. 2007 Mar-Apr;18(2):30-2. No abstract available.

PMID:
17390488
15.

Path of least resistance. New drug development guidance needed from FDA.

Huff B.

GMHC Treat Issues. 2006 Apr-Jul;20(4-7):12. No abstract available.

PMID:
17228451
16.

World CAB meets with Gilead.

Huff B.

GMHC Treat Issues. 2006 Apr-Jul;20(4-7):6-8. No abstract available.

PMID:
17228449
17.

The state of access to Kaletra.

Huff B.

GMHC Treat Issues. 2006 Apr-Jul;20(4-7):4-5. No abstract available.

PMID:
17228448
18.

New HIV drugs needed for the next decade.

Huff B.

GMHC Treat Issues. 2006 Apr-Jul;20(4-7):1-3. No abstract available.

PMID:
17228447
19.

Perceived changes in well-being: the role of chronological age, target age, and type of measure.

Okun MA, Dittburner JL, Huff BP.

Int J Aging Hum Dev. 2006;63(4):259-78.

PMID:
17191434
20.

Methamphetamine and HIV.

Huff B.

BETA. 2006 Summer;18(4):42-7.

PMID:
17019790

Supplemental Content

Loading ...
Support Center